← FDA DRUG APPROVALS

FDA ANDA · ANDA207635

BUTALBITAL AND ACETAMINOPHEN

Sponsor: ALVOGEN

APPLICATION
ANDA207635
TYPE
ANDA
ORIGINAL APPROVAL
2017-06-05
LATEST ACTION
2017-06-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BUTALBITAL AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 300MG, BUTALBITAL 50MG · TABLET · ORAL

Approval history

2017-06-05UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →